TIP Search

CLOSE


Journal of Korean Society Quality Assurance Health Care 1997;3(2): 36.
Published online March 30, 1997.
전립선비대증의 진료지침 개발
유승흠1, 채수응2, 김춘배3, 강명근3, 송재만4, 이은식5, 이정구6, 이춘용7, 홍성준8
1연세대학교 의과대학 예방의학교실
2삼성서울병원 비뇨기과
3연세대학교 원주의과대학 예방의학교실
4연세대학교 원주의과대학 비뇨기과학교실
5서울대학교 의과대학 비뇨기과학교실
6고려대학교 의과대학 비뇨기과학교실
7한양대학교 의과대학 비뇨기과학교실
8연세대학교 의과대학 비뇨기과학교실
Development of a Clinical Practice Guideline : Benign Prostatic Hyperplasia
Seung-Hum Yu1, Soo Eung Chai2, Chun-Bae Kim3, Myung Geun Kang3, Jae Mann Song4, Eun Sik Lee5, Jung Gu Lee6, Tchun Yong Lee7, Sung Joon Hong8
1Dept. of Preventive Medicine College of Medicine, Yonsei Univ.
2Dept. of Urology Samsung Medical Center
3Dept. of Preventive Medicine Wonju College of Medicine, Yonsei Univ.
4Dept. of Urology Wonju College of Medicine, Yonsei Univ.
5Dept. of Urology College of Medicine, Seoul Univ.
6Dept. of Urology College of Medicine, Korea Univ.
7Dept. of Urology College of Medicine, Hanyang Univ.
8Dept. of Urology College of Medicine, Yonsei Univ.
Abstract
Background
Clinical practice guidelines define "systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances" and help to improve patient care. The purpose of this study is to develop a clinical practice guideline for the most effective diagnoses and treatments of benign prostatic hyperplasia based on patient preference and clinical need.
Methods
For this research project, extensive literature searches (208 articles) were conducted. As well, critical reviews and syntheses (meta-analysis) were used to evaluate empirical evidence and significant outcomes of the BPH literature. Questionnaires about clinical practice for BPH patients were distributed and consensus meetings were undertaken to grasp variations in clinical practice and to reach agreement on the guideline's development. The guideline was promoted under the sponsorship of the Korean Medical Association and the Korean urological Cancer. Society. For the task, the Benign Prostatic Hyperplasia Guideline Panel was composed of multidisciplinary experts in the field.
Results
BPH is a disease that affects a patient's quality of life. This Clinical Practice Guideline was developed for the typical man over age 50 with symptoms of prostatism, but with no significant medical morbidities such as diabetes or other known causes of voiding dysfunction, such as urethral stricture or neurogenic bladder. The guidelines detail the relative benefits and obstacles associated with all diagnostic and treatment approaches, including watchful waiting.
Conclusion
This guideline provides a cornerstone for our medical association. It represents the most current scientific knowledge regarding the development, diagnosis, and treatment of BPH. It will be revised and updated as needed.
Key words Clinical Practice Guideline;Benign Prostatic Hyperplasia;Meta-analysis;Consensus Meeting;


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
FOR AUTHORS AND REVIEWERS
Editorial Office
#202-1, 71 Ihwajang-gil, Jongno-gu, Seoul, 03087 Korea
Tel: +82-2-3668-7381    E-mail: kosqua1994@daum.net

Copyright © Korean Society for Quality in Health Care. All rights reserved.

Developed in M2community

Close layer
prev next